Glenn F. Pierce

Glenn F. Pierce

Director/Board Member bij VOYAGER THERAPEUTICS, INC.

Vermogen: 181 276 $ op 29-02-2024

68 jaar
Health Technology
Consumer Services
Commercial Services

Profiel

Presently, Glenn F.
Pierce
is Chief Medical Officer & Senior Vice President at Bioverativ Therapeutics, Inc. Dr. Pierce is also on the board of World Federation of Hemophilia and Voyager Therapeutics, Inc. and Member of American Society of Hematology, Member of The International Society On Thrombosis & Haemostasis and Member of Hemostasis & Thrombosis Research Society.
He previously held the position of Chief Medical Officer & SVP-Global Medical Affairs at Biogen, Inc., Chief Medical Officer of Ambys Medicines, Inc., Principal at Amgen, Inc., Vice President-Therapeutic Product Development at Selective Genetics, Inc. and Vice President-PreClinical Development at Prizm Pharmaceuticals, Inc. (a subsidiary of Selective Genetics, Inc.), Vice President-Research & Clinical Development at Avigen, Inc., Vice President-Applied Research Hematology at Bayer Healthcare LLC and President for National Hemophilia Foundation.
He received a doctorate and an undergraduate degree from Case Western Reserve University and a graduate degree from Washington University in St. Louis.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
06-06-2023 21 788 ( 0.05% ) 181 276 $ 29-02-2024

Actieve functies van Glenn F. Pierce

BedrijvenFunctieBegin
VOYAGER THERAPEUTICS, INC. Director/Board Member 05-01-2017
Hemostasis & Thrombosis Research Society Corporate Officer/Principal -
World Federation of Hemophilia Director/Board Member 01-01-2015
Corporate Officer/Principal -
The International Society On Thrombosis & Haemostasis Corporate Officer/Principal -
Chief Tech/Sci/R&D Officer 25-01-2011
Alle actieve functies van Glenn F. Pierce

Eerdere bekende functies van Glenn F. Pierce

BedrijvenFunctieEinde
GLOBAL BLOOD THERAPEUTICS, INC. Director/Board Member 05-10-2022
Chief Tech/Sci/R&D Officer 01-08-2020
BIOGEN INC. Chief Tech/Sci/R&D Officer 01-05-2014
░░░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Ervaring van Glenn F. Pierce in detail bekijken

Opleiding van Glenn F. Pierce

Washington University in St. Louis Graduate Degree
Case Western Reserve University Doctorate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Glenn F. Pierce in detail bekijken

Connecties

100 +

Eerstegraads connecties

17

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven3
AMGEN INC.

Health Technology

BIOGEN INC.

Health Technology

VOYAGER THERAPEUTICS, INC.

Health Technology

Bedrijven in privébezit12

Health Technology

Health Technology

Health Technology

World Federation of Hemophilia

Prizm Pharmaceuticals, Inc.

Health Technology

Health Technology

Commercial Services

National Hemophilia Foundation

The International Society On Thrombosis & Haemostasis

Hemostasis & Thrombosis Research Society

Health Technology

Health Technology

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Glenn F. Pierce